Current trends among pediatric ophthalmologists to decrease myopia progression—an international perspective
| العنوان: | Current trends among pediatric ophthalmologists to decrease myopia progression—an international perspective |
|---|---|
| المؤلفون: | Eedy Mezer, Sonal K. Farzavandi, Rosario Gómez-de-Liaño, Derek T. Sprunger, Tamara Wygnanski-Jaffe, Ofira Zloto |
| المصدر: | Graefe's Archive for Clinical and Experimental Ophthalmology. 256:2457-2466 |
| بيانات النشر: | Springer Science and Business Media LLC, 2018. |
| سنة النشر: | 2018 |
| مصطلحات موضوعية: | Adult, Male, Pediatrics, medicine.medical_specialty, Adolescent, genetic structures, Young Adult, 03 medical and health sciences, Cellular and Molecular Neuroscience, 0302 clinical medicine, Surveys and Questionnaires, Myopia, Humans, Medicine, 030212 general & internal medicine, Israel, Child, Strabismus, Prospective cohort study, Societies, Medical, Dioptre, Retrospective Studies, Singapore, Ophthalmologists, Practice patterns, business.industry, Incidence, Behavioral treatment, Treatment options, Prognosis, United States, eye diseases, Sensory Systems, Ophthalmology, Spain, Child, Preschool, Disease Progression, 030221 ophthalmology & optometry, Asian population, Female, Pediatric ophthalmology, Clinical Competence, business |
| الوصف: | To explore what the current worldwide preferred practice patterns of pediatric ophthalmologists are to decrease myopia progression among their patients. A questionnaire was sent to all members of supranational and national pediatric ophthalmology and strabismus societies. The questionnaire was fully completed by most respondents 90.10% (847 of 940 responses). Fifty-seven percent (457) routinely treat to decrease myopia progression. The most common parameter to initiate treatment was a myopic increase of 1 diopter/year or more (74.8%, 246). Seventy percent (345) prescribed eye drops. Atropine 0.01% was the most popular (63.4%, 277) followed by atropine 1% (10.9%, 48) and atropine 0.5% (8.9%, 39). Eighty-six percent (394) of the respondents advised to spend more time outdoors, to reduce the amount of time viewing screens (60.2%, 277), and cutback the use of smart phones (63.9%, 294). Most pediatric ophthalmologists treat to decrease myopia. They employ a wide variety of means to decrease myopia progression. Atropine 0.01% is the most popular and safe modality used similarly to recent reports. However, there is no consensus when treatment should be initiated. Further prospective studies are needed to elucidate the best timing to start treatment and the applicability of recent studies in the Asian population to other ethnic groups. This will improve the ability to update pediatric ophthalmologist with evidenced-based treatment options to counter the myopia epidemic. |
| تدمد: | 1435-702X 0721-832X |
| DOI: | 10.1007/s00417-018-4078-6 |
| URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4073ae7f07ae966d27c5049ef5a2ac73 https://doi.org/10.1007/s00417-018-4078-6 |
| Rights: | OPEN |
| رقم الانضمام: | edsair.doi.dedup.....4073ae7f07ae966d27c5049ef5a2ac73 |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 1435702X 0721832X |
|---|---|
| DOI: | 10.1007/s00417-018-4078-6 |